Gouvernance Terumo Corporation

4543

JP3546800008

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
2 267,50 ^JPY	+2,74%		+3,59%	-0,11%

29/06	Terumo Interventional Systems réalise la première intervention aux États-Unis avec le système d'imagerie à double capteur Opuswave	CI
11/06	Transcript : Terumo Corporation - Analyst/Investor Day

Comité Exécutif: Terumo Corporation

Dirigeant

Fonctions occupéesDepuis

Hikaru Samejima

62 ans

Chief Executive Officer	01/04/2024
President	01/04/2024

Norimasa Kunimoto

63 ans

Compliance Officer

01/04/2024

Shinji Omori

Chief Tech/Sci/R&D Officer

Tomoko Adachi

Human Resources Officer

Hiroshi Yagi

Chief Operating Officer

Jin Hagimoto

Comptroller/Controller/Auditor	-
Chief Tech/Sci/R&D Officer	-
Director of Finance/CFO	-
Investor Relations Contact	-

Toshihiko Nagata

59 ans

Chief Tech/Sci/R&D Officer

01/04/2025

Miho Mizuguchi

Compliance Officer	-
General Counsel	-

Composition du Conseil d'Administration: Terumo Corporation

Administrateur

ComitésDepuis

Toshiaki Takagi

68 ans

Chairman

01/04/2022

Keiko Hayashi

65 ans

Audit Committee
Compensation Committee	01/06/2022
Nominating Committee	01/06/2022

Hidenori Nishi

75 ans

Compensation Committee	25/06/2020
Governance Committee	25/06/2020
Nominating Committee	25/06/2020

Soichiro Uno

63 ans

Audit Committee

21/06/2019

Takanori Shibazaki

64 ans

Audit Committee

01/06/2021

Keiya Ozawa

73 ans

Director/Board Member	22/06/2021
Independent Dir/Board Member	22/06/2021

Hikaru Samejima

62 ans

Director/Board Member

01/04/2024

Toshihiko Nagata

59 ans

Director/Board Member

01/06/2024

Mari Ogiso

59 ans

Director/Board Member	01/06/2024
Independent Dir/Board Member	01/06/2024

Norimasa Kunimoto

63 ans

Director/Board Member

01/06/2023

Dernières Nominations: Terumo Corporation

22/04	Humacyte, Inc. annonce la nomination de Jim Mercadante au poste de Chief Commercial Officer	CI
02/03	Shoulder Innovations, Inc. annonce des changements au sein de son conseil d'administration	CI
16/04/25	Terumo Blood and Cell Technologies nomme Patrick Daly au poste de directeur commercial	CI
14/12/23	Shinjiro Sato quittera son poste de PDG de Terumo Corporation le 1er avril 2024	CI
14/12/23	Terumo Corporation annonce des changements de direction à compter du 1er avril 2024	CI
02/02/23	Hôtel Chocolat engage le nouveau directeur financier de la division Terumo, M. Akehurst, comme nouveau directeur financier.	AN
02/02/23	Hôtel Chocolat nomme un nouveau directeur financier	MT

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Terumo Corporation

Insider

Fonctions occupées

DepuisJusqu'au

Ikuo Mori

Director/Board Member	01/06/2014	25/06/2020
Independent Dir/Board Member	01/06/2014	25/06/2020

David Perez

Director/Board Member	01/06/2014	30/06/2019
Corporate Officer/Principal	01/06/2014	30/06/2019

Hideo Arase

Director/Board Member	07/01/2010	22/06/2018
General Counsel	14/07/2011	01/12/2014
Corporate Officer/Principal	07/01/2010	22/06/2018

Mari Matsunaga

Director/Board Member	01/06/2012	-
Independent Dir/Board Member	01/06/2012	-

Takashi Wachi

Corporate Officer/Principal

01/12/1989

29/06/2011

Kyo Nishikawa

Chief Administrative Officer	07/02/2012	-
Director/Board Member	21/06/2019	-
Human Resources Officer	01/04/2018	-
General Counsel	07/02/2012	-
Corporate Officer/Principal	14/09/2010	07/02/2012

Tadao Kakizoe

Director/Board Member	07/01/2010	-
Independent Dir/Board Member	14/07/2011	07/02/2012

Masaharu Ikuta

Director/Board Member

01/06/2008

Uichi Okina

Corporate Officer/Principal

01/01/2006

Takeshi Isayama

Director/Board Member	14/07/2011	-
Independent Dir/Board Member	14/07/2011	07/02/2012

Shinjiro Sato

Director/Board Member	01/06/2014	-
Chief Executive Officer	01/04/2017	01/04/2024
Corporate Officer/Principal	01/06/2010	01/04/2017
President	01/04/2017	01/04/2024

Kuniko Shoji

Director/Board Member	14/09/2010	-
Corporate Officer/Principal	14/09/2010	-

Tsuneo Taida

Director/Board Member	01/04/2001	-
Corporate Officer/Principal	01/04/2001	-

Yutaro Shintaku

Director/Board Member	07/01/2010	-
Corporate Officer/Principal	07/01/2010	14/09/2010
President	01/06/2010	01/04/2017

Chisato Nojiri

Corporate Officer/Principal

14/07/2011

Hiroshi Uehara

Chief Tech/Sci/R&D Officer

01/01/1985

Shouji Hatano

Director/Board Member	01/06/2016	-
Compliance Officer	01/04/2020	-
Public Communications Contact	01/04/2020	-
General Counsel	01/04/2020	-
Corporate Officer/Principal	01/04/2015	01/04/2020
Sales & Marketing	01/04/2020	-
Corporate Secretary	01/06/2009	01/10/2011

Yoshihiro Kimura

Comptroller/Controller/Auditor	01/04/2014	01/06/2017
Director/Board Member	01/06/2017	-
Chief Operating Officer	01/07/1998	01/07/2006
Corporate Officer/Principal	01/07/2008	01/04/2014

Shogo Ninomiya

Director/Board Member	07/01/2010	-
Corporate Officer/Principal	07/01/2010	-

Kenji Sekine

Comptroller/Controller/Auditor	01/06/2013	01/06/2015
Director/Board Member	07/01/2010	-
Corporate Officer/Principal	07/01/2010	01/12/2014

Takayoshi Mimura

Director/Board Member	01/06/2003	-
Chairman	01/04/2017	01/04/2022
Corporate Officer/Principal	01/06/2009	01/04/2017
Sales & Marketing	01/04/2008	01/06/2009

Hiroshi Matsumura

Director/Board Member	14/09/2010	-
Corporate Officer/Principal	14/09/2010	01/04/2017
Sales & Marketing	14/07/2011	01/12/2014

Yoshiaki Shiraishi

Comptroller/Controller/Auditor	01/06/2012	01/06/2015
Director/Board Member	01/06/2015	-

Akira Oguma

Director/Board Member	07/01/2010	-
Chief Tech/Sci/R&D Officer	14/07/2011	07/02/2012
Corporate Officer/Principal	07/01/2010	-

Yoshihiko Tosa

Comptroller/Controller/Auditor

14/09/2010

Koji Nakao

Chairman

01/05/2011

Tetsuya Kumei

Investor Relations Contact

Faranak Gomarooni

Corporate Officer/Principal

Takahiro Wakamatsu

Public Communications Contact

31/07/2009

Hiroshi Nakagomi

Corporate Officer/Principal

14/07/2011

Minoru Suzuki

Chief Tech/Sci/R&D Officer	14/07/2011	07/02/2012
Corporate Officer/Principal	-	-

Kay L. Fuller

Corporate Officer/Principal

Jef van Dam

Corporate Officer/Principal

Ryo Nishihata

Comptroller/Controller/Auditor	-	-
Director of Finance/CFO	-	-
Investor Relations Contact	-	-
Public Communications Contact	-	-

Kosuke Matsumoto

Human Resources Officer	-	25/06/2020
Sales & Marketing	25/06/2020	-

Hiroaki Kasukawa

Chief Tech/Sci/R&D Officer

Masataka Haraguchi

Corporate Officer/Principal

14/07/2011

Somsak Jarasviriyagul

Corporate Officer/Principal	14/09/2010	07/02/2012
Sales & Marketing	07/02/2012	-

Yoshiaki Akaike

Corporate Officer/Principal

14/09/2010

Richard Cappetta

Corporate Officer/Principal

14/07/2011

Mark A. Sutter

Corporate Officer/Principal

07/01/2010

Tsuyoshi Tomita

Corporate Officer/Principal

14/07/2011

Toru Kubota

Corporate Officer/Principal

07/01/2010

Narushige Toda

Corporate Officer/Principal	07/01/2010	14/07/2011
Sales & Marketing	14/07/2011	-

Kaori Kai

Corporate Officer/Principal	07/01/2010	07/02/2012
Sales & Marketing	07/02/2012	-

Yoshikazu Sano

Corporate Officer/Principal

07/01/2010

Brett E. Crawford

Corporate Officer/Principal

Jun Hoshino

Corporate Officer/Principal

Juichi Takeuchi

Corporate Officer/Principal

Kazuaki Kitabatake

Compliance Officer	-	-
Investor Relations Contact	-	25/06/2020
Public Communications Contact	-	25/06/2020
General Counsel	-	-
Corporate Officer/Principal	25/06/2020	-

Hachiro Hara

Comptroller/Controller/Auditor

07/01/2010

Akira Takahashi

Director/Board Member

14/07/2011

Shibasaburo Kitasato

Founder

17/09/1921

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	14
Femme	3

Dont comité exécutif

Homme	7
Femme	1

Dont Administrateurs

Homme	8
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Terumo Corp est une société japonaise spécialisée principalement dans la fabrication et la vente de dispositifs médicaux et de produits pharmaceutiques. La société opère dans trois segments. Le segment Cardiovascular Company propose des fils-guides pour l'angiographie, des cathéters pour l'angiographie, des gaines d'introduction, des spirales, des stents et des dispositifs d'embolisation à poche pour le traitement des anévrismes cérébraux, ainsi que des poumons artificiels et des machines cœur-poumon artificielles. Le segment Medical Care Solutions propose des solutions de soins hospitaliers, des solutions de soins de santé et des solutions pharmaceutiques. Le segment Blood and Cell Technology fournit des poches de sang, des systèmes de prélèvement de composants sanguins, des systèmes automatisés de produits sanguins, des systèmes de réduction des agents pathogènes et des séparateurs centrifuges de composants sanguins.

Employés

30 591

Secteur

Equipement, fournitures et distribution médicale

Agenda

Publication des résultats - Q1 2027

Plus d'informations sur la société